Literature DB >> 19710088

Differential effect of molecular mass hyaluronan on lipopolysaccharide-induced damage in chondrocytes.

Giuseppe M Campo1, Angela Avenoso, Salvatore Campo, Angela D'Ascola, Paola Traina, Carmela A Rugolo, Alberto Calatroni.   

Abstract

Hyaluronan is a biological polysaccharide that may exist in different degrees of polymerization. Several investigations reported that low molecular mass hyaluronan may have pro-inflammatory activity, while high molecular mass hyaluronan can exert beneficial effects. Starting from these data, the aim of this study was to investigate the effect of hyaluronan of different molecular mass in mouse articular chondrocyte cultures stimulated with lipopolysaccharide (LPS). Inflammation was induced in chondrocytes by acute treatment with 2.0 microg/ml LPS. High levels of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta, IL-6, interferon (IFN)-gamma and iNOS gene expression and their related proteins were found in chondrocytes 24 h after treatment with LPS. High concentrations of NO, NF-kappaB activation, IkappaBalpha phosphorylation and apoptosis, evaluated by the increase in caspase-3 expression and its related protein amount were also produced by LPS stimulation. In contrast, LPS reduced aggrecan and collagen type II (Col2A) expression and their protein production. The treatment of chondrocytes with hyaluronan of different molecular mass produced the following effects: (i) low molecular mass hyaluronan exerted a slight inflammatory effect in untreated chondrocytes, while in LPS-treated chondrocytes it enhanced cytokine production and decreased aggrecan and Col2A compared with cells treated with LPS alone; (ii) no effect was exerted on LPS-induced apoptosis and NO production; (iii) medium molecular mass hyaluronan did not exert any inflammatory/anti-inflammatory activity in LPS-untreated/treated cells and failed to reduce apoptosis; and (iv) high molecular mass hyaluronan had no inflammatory effect in LPS-untreated cells while it was able to reduce all the detrimental effects stimulated by LPS treatment. These data confirm the multifactorial role played by hyaluronan and suggest, in particular, that hyaluronan may modulate inflammation during pathologies by its different degrees of polymerization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19710088     DOI: 10.1177/1753425909340419

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  12 in total

Review 1.  Hyaluronan in the experimental injury of the cartilage: biochemical action and protective effects.

Authors:  Angela Avenoso; Angela D'Ascola; Michele Scuruchi; Giuseppe Mandraffino; Alberto Calatroni; Antonino Saitta; Salvatore Campo; Giuseppe M Campo
Journal:  Inflamm Res       Date:  2017-08-12       Impact factor: 4.575

2.  Characterization of and host response to tyramine substituted-hyaluronan enriched fascia extracellular matrix.

Authors:  Likang Chin; Anthony Calabro; E Rene Rodriguez; Carmela D Tan; Esteban Walker; Kathleen A Derwin
Journal:  J Mater Sci Mater Med       Date:  2011-05-07       Impact factor: 3.896

3.  Treatment with the hyaluronic Acid synthesis inhibitor 4-methylumbelliferone suppresses LPS-induced lung inflammation.

Authors:  Robert J McKallip; Hao Ban; Olga N Uchakina
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

4.  High and low molecular weight hyaluronic acid differentially influence macrophage activation.

Authors:  Jamie E Rayahin; Jason S Buhrman; Yu Zhang; Timothy J Koh; Richard A Gemeinhart
Journal:  ACS Biomater Sci Eng       Date:  2015-07-13

5.  A randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis.

Authors:  Francis Berenbaum; Joachim Grifka; Sara Cazzaniga; Massimo D'Amato; Giampaolo Giacovelli; Xavier Chevalier; Francois Rannou; Lucio C Rovati; Emmanuel Maheu
Journal:  Ann Rheum Dis       Date:  2012-01-31       Impact factor: 19.103

6.  Hyaluronan synthase-2 upregulation protects smpd3-deficient fibroblasts against cell death induced by nutrient deprivation, but not against apoptosis evoked by oxidized LDL.

Authors:  Sandra Garoby-Salom; Myriam Rouahi; Elodie Mucher; Nathalie Auge; Robert Salvayre; Anne Negre-Salvayre
Journal:  Redox Biol       Date:  2014-12-16       Impact factor: 11.799

7.  Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation.

Authors:  Philipp R Esser; Ute Wölfle; Christoph Dürr; Friederike D von Loewenich; Christoph M Schempp; Marina A Freudenberg; Thilo Jakob; Stefan F Martin
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

8.  Hyaluronan-CD44 interaction promotes growth of decidual stromal cells in human first-trimester pregnancy.

Authors:  Rui Zhu; Song-Cun Wang; Chan Sun; Yu Tao; Hai-Lan Piao; Xiao-Qiu Wang; Mei-Rong Du
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240

9.  Bacterial lipopolysaccharides form procollagen-endotoxin complexes that trigger cartilage inflammation and degeneration: implications for the development of rheumatoid arthritis.

Authors:  Wolfgang Lorenz; Constanze Buhrmann; Ali Mobasheri; Cora Lueders; Mehdi Shakibaei
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

10.  A Systematic Study of the Effect of Different Molecular Weights of Hyaluronic Acid on Mesenchymal Stromal Cell-Mediated Immunomodulation.

Authors:  Alejandro Gómez-Aristizábal; Kyung-Phil Kim; Sowmya Viswanathan
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.